Cnat stock yahoo
LXRX Lexicon Pharmaceuticals, Inc. daily Stock Chart 09:57AM, FDA denies appeal of decision over Lexicon Pharmas diabetes drug Yahoo Finance Video Mar-27-19 10:55AM, Biotech Stock Roundup: BIIB & CNAT Crash on Study London Stock Exchange Group PLC. LSE.L. GBP. LVMH Moet Exxon Mobil Corp. XOM.N. USD. Dentsply Sirona Inc. XRAY.OQ. USD. Yahoo. YHOO.OQ. USD. The Complete List of Biotech Stocks Trading on the NASDAQ as of April 6, 2020 are listed below: Note: If you are 190, Conatus Pharmaceuticals Inc. CNAT. (https://finance.yahoo.com/news/analysts-bet-trevena-trvn-pain-003603980.html). $GERN --- Sad I didn't I feel like I missed the boat on $CNAT. I have been Looking for some low priced Bio/Pharma stocks to throw some cash on. ( besides the occasional news reports on yahoo) have been released by companies. Conatus Pharmaceuticals Inc. (CNAT) Stock ... - Yahoo Finance
investment & stock information. Get the latest Conatus Pharmaceuticals Inc. CNAT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
CNAT - Stock quote for CONATUS PHARMACEUTICALS INC. - … View the latest CNAT stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of CONATUS PHARMACEUTICALS INC.. Conatus Pharmaceuticals (CNAT) Stock Price History | wallmine May 04, 2018 · Conatus Pharmaceuticals, Inc. is a biotechnology company, which engages in the development and commercialization of medicines for the treatment of liver diseases. It focuses in development of emricasan, an orally active pan-caspase inhibitor, for the treatment of patients with chronic liver disease, which reduce the activities of human caspases. Conatus Pharmaceuticals Inc. Common Stock (CNAT) Option ...
CNAT Stock Price | Conatus Pharmaceuticals Inc. Stock ...
CNAT Conatus Pharmaceuticals Inc. Stock Quote
CNAT Price Target and Analyst Ratings (Conatus ...
Conatus Pharmaceuticals Inc's stock rating is based on fundamental analysis. Don't miss CNAT stock next rating changes CNAT Stock Price & Charts | Conatus Pharmaceuticals In depth view into CNAT (Conatus Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials. $CNAT Stock Technical Analysis | Conatus | SwingTradeBot.com Nov 06, 2019 · CNAT on Yahoo! Finance; CNAT on TradingView; CNAT on StockCharts.com; Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of medicines to treat liver diseases in the United States. Its products include Emricasan, an orally active caspase protease inhibitor for the treatment of acute-on-chronic Conatus Pharmaceuticals Inc. (CNAT) Foro de ... - Yahoo Encuentra el debate de accionesConatus Pharmaceuticals Inc.(CNAT) más reciente en el foro de Yahoo Finanzas. Comparte tu opinión y gana perspectiva de otros corredores de bolsa e inversionistas.
View the latest CNAT stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of CONATUS PHARMACEUTICALS INC..
CNAT Price Target and Analyst Ratings (Conatus ... Nov 04, 2019 · Their average twelve-month price target is $1.50, suggesting that the stock has a possible upside of 383.87%. The high price target for CNAT is $1.50 and the low price target for CNAT is $1.50. There are currently 1 hold rating for the stock, resulting in a consensus rating of "Hold."
CNAT | Complete Conatus Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Conatus Pharmaceuticals Inc. (CNAT) stock forum ...